15th Asia Pacific Breast Cancer Summit
World-leading experts sharing the latest advances in breast cancer care at APBCS 2027 in Singapore.
Click on a speaker to read their full biography. More faculty will be announced soon.
National Cancer Centre Singapore
Singapore
National Cancer Centre SingaporeAssistant Professor Ng graduated from Otago Medical School in New Zealand in 1994 and subsequently attained his specialist oncology fellowship from the Royal Australasian College of Physicians in 2004. Following this he spent a year as a Clinical Research Fellow at Royal Melbourne Hospital in Australia and subsequently an additional two years as a Clinical Fellow at Princess Margaret Hospital in Toronto, Canada. His work in Canada focused primarily on clinical care as well as a special interest on health outcomes research in breast and lung cancer. He returned to Singapore in 2007 as an Associate Consultant at the National Cancer Centre Singapore and is now currently a Senior Consultant within the breast oncology team. In this intervening period he also completed a Master in Public Health from NUS in 2010. He is passionate about medical education and spends part of his time every week lecturing and mentoring medical students at the University. In addition to his clinical and educational duties, he also provides consultation work with the Agency for Care Effectiveness at the Ministry of Health.
Singapore General Hospital
Singapore
Singapore General HospitalProfessor Tan Puay Hoon is a Senior Consultant Histopathologist and Chairperson, Division of Pathology at SGH. She has active interests in breast, urologic and renal pathology. Prof Tan’s research interests in breast pathology centre around the classification of breast fibroepithelial lesions and their molecular pathogenesis, triple negative breast cancers, and ductal carcinoma in situ. She is the author of more than 500 publications and participates regularly in regional and international meetings. Together with her collaborators, she has received several research grants related to translational studies of breast and prostate cancer.
National Cancer Centre Singapore
Singapore
National Cancer Centre SingaporeDr. Amanda Liew graduated with honours from the University of Edinburgh in 2014 and became a Fellow of the Royal College of Radiologists in 2018. She completed her residency training in Singapore and obtained her specialist accreditation in Diagnostic Radiology in 2021. She currently serves as the Director of Breast Imaging in the Radiological Sciences Academic Clinical Programme (RADSC ACP) of the SingHealth Duke-NUS Academic Medical Centre and is also the Site-lead for National Cancer Centre Singapore in Breast Radiology at SingHealth Duke-NUS Breast Centre. She received the Outstanding Faculty Awards in 2025 and 2024, the Singapore Health Quality Service Silver Award in 2024 and led an award-winning quality improvement project in 2023. She has a special interest in breast imaging, breast cancer research and education. She also plays an active role in the breast imaging community in Singapore and has presented in both local and international conferences.
University of Calgary
Canada
University of CalgaryDr. May Lynn Quan is a Professor of Surgery and Oncology at the University of Calgary. She completed her breast surgical oncology training at Memorial Sloan Kettering Cancer Center and currently practices at the Arthur JE Child Comprehensive Cancer in Calgary, Canada. She serves as Co-President of the Canadian Society of Breast Surgeons and is the Scientific Director of Strategies for Precision Health in Breast Cancer (SPHERE). Her research focuses on breast cancer outcomes, particularly in young women, and improving the delivery of surgical and multidisciplinary care. Through clinical and health services research, she works to optimize patient pathways from diagnosis through surgery to survivorship, with an emphasis on evidence-based, patient-centred care.
Singapore General Hospital
Singapore
Singapore General HospitalDr Ian Tay is a Consultant Breast Radiologist with SGH. He has special interests in breast intervention procedures and medical education. He also serves as Programme Director of the Singhealth Diagnostic Residency Programme.
National University Health System
Singapore
National University Health SystemAdjunct Associate Professor Andrea Wong completed her undergraduate medical degree at the University of Glasgow and obtained her postgraduate qualifications from the Royal College of Physicians, United Kingdom and the National University of Singapore. She practices at the Department of Haematology-Oncology, National University Cancer Institute, Singapore (NCIS), where she serves as the Head of Department and specializes in breast cancer as well as neuro-oncology. She actively contributes to cancer research by playing an active leadership role in the management of Haematology-Oncology Research Group, the key clinical trials infrastructure at NCIS, as well as through her role as Principal Investigator and Co-Investigator of multiple clinical trials including breast cancer, neuro-oncology and early phase clinical trials.
Singapore Chung Hwa Medical Institution
Singapore
Singapore Chung Hwa Medical InstitutionWilliam Peh Wei Liang is a Singapore TCM physician with degrees in biomedical sciences and Chinese Medicine from Nanyang Technological University and Beijing University of Chinese Medicine. He also holds master’s degrees in clinical investigation (NUS) and TCM internal medicine oncology (Liaoning University of Chinese Medicine). He co-authored three papers, two dissertations, one book, and twelve Singapore Journal of TCM articles on cancer. His research examines efficacy and cost-effectiveness of integrated TCM and conventional care. As COO and Consultant Physician at Singapore Chung Hwa Medical Institution, he teaches and serves on MOH sandbox, TCM Practitioners Board, and TCM oncology committees.
National Cancer Centre Singapore
Singapore
National Cancer Centre SingaporeDr Chay Wen Yee is a Consultant medical Oncologist at National Cancer Centre Singapore with an interest in gynaecological cancers and breast cancer. She is also a visiting consultant at the Department of Gynecological Oncology, KK Women and Children’s Hospital as well as an adjunct Assistant Professor, Department of Medicine, Singhealth Duke-NUS Oncology Academic Clinic Programme. Dr Chay’s research interests lie mainly in gynecological cancers particularly in the identification of biomarkers in mucinous ovarian cancer. She is involved in various investigator initiated as well as industry sponsored trials, both in the capacity of principal investigator and co-investigator. She is a keen educator and is faculty for Duke-NUS Graduate Medical School as well as clinical tutor for Yong Loo Lin School of Medicine.
Singapore Thong Chai Medical Institution
Singapore
Singapore Thong Chai Medical InstitutionQuan Ming is a licensed Chinese Medicine Practitioner at the Singapore Thong Chai Medical Institution. He collaborates on clinical research with the National Cancer Centre Singapore, focusing on supportive care for cancer survivors. He is also pursuing training in palliative care to further thoughtful and integrative care within the community.
Solis Breast Care & Surgery Centre
Singapore
Solis Breast Care & Surgery CentreDr. Esther Chuwa is a Senior Consultant Breast Surgeon and founding member of Solis Breast Care & Surgery Centre, Singapore. She specialises in breast surgical oncology, with particular expertise in oncoplastic breast-conserving surgery and minimally invasive breast procedures. Trained at the National University of Singapore and Nottingham Breast Institute, UK, she has also undertaken clinical observerships at leading international cancer centres. An active clinician-researcher, Dr Chuwa has published on breast diseases and surgical outcomes, and serves as a reviewer for international medical journals. She is passionate about advancing evidence-based, patient-centred breast cancer care through surgical innovation, research and education.
Singapore General Hospital
Singapore
Singapore General HospitalTimothy has a special interest in Breast, Bone and Soft Tissue and Molecular Pathology and was awarded the SingHealth Health Manpower Development Plan (HMDP) Fellowship to pursue further training at the Memorial Sloan Kettering Cancer Centre in New York, USA as well as Institute of Pathology, Heidelberg University Hospital, Germany. Timothy currently holds a Senior Consultant position at the Singapore General Hospital Department of Anatomical Pathology within which he also heads the Anatomical Molecular Laboratory (former Translational Pathology Centre).
National Cancer Centre Singapore
Singapore
National Cancer Centre SingaporeClin Asst Prof Faye Lynnette Lim Wei Tching is a Senior Radiation Oncologist at the National Cancer Centre Singapore who specializes in both Breast and Gastrointestinal Cancers. She trained at the Mount Vernon Cancer Centre and the University College London Hospitals in the United Kingdom. She has a special interest in the use and optimization of proton therapy and is the Clinical Lead for proton therapy in the treatment of breast cancer.
Singapore General Hospital
Singapore
Singapore General HospitalMs Jeraldine Seah is a Senior Acupuncturist at Singapore General Hospital. She graduated from the pioneer batch of the joint double degree programme in Chinese Medicine and Biomedical Sciences by Nanyang Technological University and Beijing University of Chinese Medicine in 2010. With more than 10 years of clinical experience, she has an acute interest in the use of acupuncture for pain management, insomnia, anxiety, gastrointestinal disorders and gynecological problems.
National Cancer Centre Singapore
Singapore
National Cancer Centre SingaporeDr Mabel Wong is a Senior Consultant and Head of Department of the Breast and Gynaecology Oncology, Division of Medical Oncology at National Cancer Centre Singapore, and Visiting Senior Consultant, Breast Service, KK Hospital. She obtained her undergraduate medical degree from the National University of Singapore. Dr. Mabel has been practicing in Singapore since 2001, focusing mainly on medical oncology since 2008. Her research interests include clinical trials in breast and gynaecology oncology and neo-adjuvant therapy in breast cancer. She is a Clinical Assistant Professor at Duke-NUS Medical School, Physician Faculty for Senior Residency Program (Medical Oncology), and Clinical Assistant Professor at the Yong Loo Lin School of Medicine, Singapore.
Khoo Teck Puat Hospital
Singapore
Khoo Teck Puat Hospital"Dr Lester Leong is a Senior Consultant and Head of the Breast Imaging Subspecialty in the Department of Diagnostic Radiology at Khoo Teck Puat Hospital, Singapore. He completed his specialist training in Diagnostic Radiology in Singapore before pursuing subspecialty training in breast imaging. In 2010, he was awarded the SingHealth Human Resource Development Programme Scholarship to undertake a breast imaging fellowship at Brigham and Women's Hospital in Boston, Massachusetts, USA. He subsequently completed a second fellowship in breast imaging at St Bartholomew's Hospital in London, United Kingdom. He has a strong interest in breast imaging research and has authored several publications in the field, with particular focus on breast cancer screening, ultrasound elastography, imaging assessment of axillary lymph nodes, and the application of artificial intelligence in breast imaging. Dr Leong previously served as Chair of the Chapter of Diagnostic Radiologists, College of Radiologists, Singapore (2015–2019), and as inaugural Chair of the Breast Imaging Subsection of the Singapore Radiological Society (2015–2017). He is also a passionate educator and was a longstanding core faculty member for the breast imaging curriculum in the SingHealth Diagnostic Radiology Residency Programme from 2010 to 2022. In addition, he is one of the founding members of the Asian Oceanian Society of Breast Imaging. "
Prashanti Cancer Care Mission, Pune
India
Prashanti Cancer Care Mission, PuneDr. Chaitanyanand Koppiker is a distinguished Breast Cancer, Breast Oncoplastic and Reconstructive Surgeon based in Pune, India, with a strong commitment to advancing breast cancer care, surgical education, and clinical and translational research. He currently serves as the Director of Oncosciences at Jehangir Hospital and Director and Managing Trustee of Prashanti Cancer Care Mission (PCCM). He is also the Medical Director of PCCM’s Orchids Breast Health, where he leads initiatives focused on comprehensive breast healthcare, and as Principal Investigator of PCCM’s Centre for Translational Cancer Research spearheads research activities at the centre. A dedicated advocate for advancing oncoplastic breast surgery through education and international collaboration, Dr. Koppiker is the Founding Director of the International School of Oncoplastic Surgery (ISOS) and Breast Global Network. His academic and international engagements include serving as an Honorary Associate Professor at the University of East Anglia, UK, and as a Member of the Board of Directors and Visiting Faculty at the School of Oncoplastic Surgery, California, USA. Through his clinical, academic, and leadership roles, Dr. Koppiker continues to contribute to advancing breast cancer treatment, surgical training, and research.
National Cancer Centre Singapore
Singapore
National Cancer Centre SingaporeDr Toh Ching Han is an associate consultant at the National Cancer Centre Singapore. She obtained her undergraduate medical degree from the Lee Kong Chian School of Medicine Singapore and completed her postgraduate qualifications in Internal Medicine by the Royal College of Physicians of United Kingdom. She went on to complete her advanced specialist training in Medical Oncology and currently has clinical and research interest in breast and gynaecological cancers.
National Cancer Center Singapore
Singapore
National Cancer Center SingaporeProfessor Alexandre Chan is a Founding Chair and Professor in Clinical Pharmacy at the University of California, Irvine (UCI) School of Pharmacy and Pharmaceutical Sciences. He is a Visiting Professor at National Cancer Center Singapore, Adjunct Faculty at Duke-NUS, and a Clinical Pharmacist at the Chao Family Comprehensive Cancer Center in Orange, USA. A board-certified specialist in Pharmacotherapy and Oncology Pharmacy, Alex has published over 330 peer-reviewed manuscripts in a wide array of cancer-supportive care and survivorship topics in medical and pharmacy journals, and his research program has attracted approximately 10 million USD competitive funding support from various governmental agencies (NIH in the USA, NMRC in Singapore), foundations, and pharmaceutical companies. Alex is an elected Fellow of the American College of Clinical Pharmacy and the International Society of Oncology Pharmacy Practitioners (ISOPP). He is currently serving as a Vice Chair for the Board of Pharmacy Specialties (BPS) Oncology Pharmacy Specialty Council. He was a Past President of ISOPP, and he is currently the President-Elect of the Multinational Association of Supportive Care in Cancer (MASCC).
Singapore General Hospital
Singapore
Singapore General HospitalDr Mothi Babu graduated from Madras Medical College, India with Bachelor of Medicine, Bachelor of Surgery (MBBS) and became a Member of Royal Colleges of Physicians of the United Kingdom (MRCP, UK) in 2015. He completed his Basic Specialist Training in Internal Medicine in 2014 and ACGME-I accredited Senior Residency training in Rehabilitation Medicine in Singapore. (2014 – 2017). Dr Mothi completed an international observership in Cancer Rehabilitation and a Fellowship in Integrative Medicine from Memorial Sloan Kettering Cancer Center , USA. between January to June 2024. His clinical areas of interest include Cancer Rehabilitation, Cancer survivorship and Exercise Oncology, Metastatic Spinal Cord Injury, Integrative Medicine in Oncology and Pain Management in Cancer. He is also passionate about medical education both at undergraduate and post graduate level.
PICASO Hospital
Malaysia
PICASO HospitalDr. Mastura Md. Yusof is a Consultant Clinical Oncologist and Head of the Cancer Centre at PICASO Hospital and Pantai Hospital Kuala Lumpur, She leads the research unit at Pantai Hospital Kuala Lumpur, overseeing numerous clinical trials in breast and lung cancer including fundamental trials that resulted in the approval of pembrolizumab in metastatic triple negative breast cancer. She is actively participating in international clinical trials in varied innovative therapies such as targeted therapies, PARP inhibitors, immunotherapies and antibody-drug conjugates and has co-authored numerous peer-reviewed publications in national and international journals.
University of California Irvine
USA
University of California IrvineDr. Gary Deng is Professor of Medicine and the Samueli Endowed Chair in Integrative Oncology at the University of California, Irvine (UCI). He serves as an Associate Director of the UCI Chao Family Comprehensive Cancer Center, Director of Clinical Affairs at the Susan Samueli Integrative Health Institute, and Program Director of Integrative Oncology at UCI Health. His professional expertise lies in an integrative, whole-person approach to health—supporting patients across the continuum of cancer prevention, treatment, and survivorship. He is principal investigator for federally funded research and clinical trials on acupuncture, yoga, and botanical agents, and has led the development of educational programs that have trained numerous physicians and researchers in integrative oncology. His scholarly work includes clinical practice guidelines, clinical trials, reviews, and textbook chapters. Dr. Deng is a member of the National Cancer Institute whole person care think tank and reviews grant proposals for the National Institute of Health. Dr. Deng is a past president of the Society for Integrative Oncology, the founding Medical Director of Integrative Medicine at MSK, and a former Professor of Clinical Medicine at Weill Cornell Medical College of Cornell University. He earned his medical degree from Beijing Medical University in China and a Ph.D. in Microbiology and Immunology from the University of Miami. He completed clinical training at the University of Texas Medical School in Houston and research training at the University of Texas MD Anderson Cancer Center.
City of Hope Comprehensive Cancer Center
USA
City of Hope Comprehensive Cancer CenterHope S. Rugo, MD, FASCO, is a medical oncologist and hematologist specializing in breast cancer research and treatment. She is a Professor of Medicine, Director of the Women’s Cancers Program, and Division Chief of Breast Medical Oncology at City of Hope. Formerly, Dr. Rugo was Director of Breast Oncology and Clinical Trials Education at UCSF, where she is Professor Emeritus. Her research focuses on combining novel therapies with standard treatments to improve outcomes for both early and late-stage breast cancer and supportive care.. She lectures globally and advances patient care through research, education, and clinical practice.
International Breast Cancer Center (IBCC), Barcelona/ IOB Madrid, Institute of Oncology Madrid
Spain
International Breast Cancer Center (IBCC), Barcelona/ IOB Madrid, Institute of Oncology MadridDr. Cortés is the Head of the International Breast Cancer Centre (IBCC) in Barcelona and co-director of IOB in Madrid, founding partner of Medica Scientia innovation Research (MedSIR). According to the American Expertscape 2023 ranking, he is considered the world’s leading expert on HER2+ and fourth world oncologist with the greatest expertise in breast cancer and in 2022 and 2023 was identified as Clarivate™ world’s most influential researchers.
UNC Lineberger Comprehensive Cancer Center
USA
UNC Lineberger Comprehensive Cancer CenterLisa A. Carey MD, ScM, FASCO, is the Jacobs Preyer Distinguished Professor for Breast Cancer Research at the University of North Carolina, Deputy Director of Clinical Sciences at UNC Lineberger Comprehensive Cancer Center, and Chief Clinical Research Officer for UNC Health. Her research focuses on clinical application of breast cancer molecular subtypes and clinical trials of novel therapies. She co-chairs the Alliance Breast Committee and the Executive Committee of the Translational Breast Cancer Research Consortium. Honors include the NCI Director's Service Award, Giants of Cancer Care Award, Brinker Award for Clinical Research, and recognition as a Clarivate Highly Cited Researcher.
Universiti Malaya
Malaysia
Universiti MalayaProfessor Nirmala Bhoo-Pathy is a public health physician and epidemiologist at Universiti Malaya, internationally recognised for her work on the economic and social consequences of cancer in low- and middle-income countries. As Principal Investigator of the ASEAN Costs in Oncology (ACTION) study and related research on financial toxicity and survivorship, she has generated policy-relevant evidence on how cancer pushes households into financial hardship and which protections are most effective. She has held several global leadership roles, including Economic Section Lead of the Lancet Oncology Commission on the Human Crisis in Cancer, Commissioner of the Lancet Commission on Women, Power and Cancer, and currently the Lancet Commission on Cancer and Health Sytems, and Lancet Oncology Commission on Cancer Genomics. She also serves on the Steering Committee of the Global Alliance for Cancer Patient Navigation and contributes to the WHO Global Breast Cancer Initiative Patient Navigation Framework.
Penang Adventist Hospital
Malaysia
Penang Adventist HospitalDr Kiley Loh is a medical oncologist specializing in breast cancers and cancer supportive and survivorship care at the Penang Adventist Hospital in Malaysia. Dr Loh graduated from the University of Melbourne in 2005, before undergoing medical oncology training with the Victorian Medical Oncology Training Program at several Melbourne-based hospitals, including the Peter MacCallum Cancer Centre. He joined National Cancer Centre Singapore (NCCS) in 2014 after the completion of his training and went on to subspecialize in the field of breast cancers.
Prince Court Medical Centre
Malaysia
Prince Court Medical CentreDr. Muhammad Azrif graduated from the Royal Free Hospital & University College London School of Medicine, London, UK in 1997. After completing his training in internal medicine and obtaining his MRCP (UK) in 2000, he entered the specialist training program in Clinical Oncology at the Christie Hospital, Manchester, UK. He became a Fellow of the Royal College of Radiologists (Clinical Oncology) in 2005 and attained his Certificate of Completion of Specialist Training (UK) before admission to the UK General Medical Council Specialist Register in 2006. He was awarded a one-year Clinical Research Fellowship to the Department of Radiation Oncology, University of Toronto, Canada in mid-2006. He returned to Malaysia in 2007 and served at the National University of Malaysia Medical Centre (UKMMC) as a Consultant Clinical Oncologist for 5 years before joining private practice in 2012. He has served on various national oncology committees, published in peer-reviewed journals as well as participated in numerous clinical trials, cancer advisory boards, and expert panels.
Graduate School of Medicine, Kyoto University
Japan
Graduate School of Medicine, Kyoto UniversityMasakazu Toi graduated in 1982 from Hiroshima University School of Medicine with his Medical Doctorate and in 1988 with his PhD. He studied at the Institute of Molecular Medicine at Oxford University, UK, from 1990 to 1992. In 2007, Professor Toi was appointed Professor of Breast Surgery at the Graduate School of Medicine, Kyoto University, Japan, and Director of the Breast Cancer Unit, Kyoto University Hospital. Professor Toi is passionate in his study of cancer, particularly breast cancer biology and treatment. He is keen on research that translates basic science into clinical study. He is involved in various innovative research projects on the development of new anticancer diagnostics and therapeutics including biomarkers, novel imaging and antibody treatment. He is engaged in clinical trials mainly associated with breast cancer treatment and research. He has a strong interest in the tumour microenvironment such as angiogenesis and stromal reactions. Professor Toi belongs to various associations and is a member of several leading academic organizations. He serves as an editorial board member of multiple academic journals and has authored or co-authored over 300 articles.
Centre Jean Perrin
France
Centre Jean PerrinFrédérique PENAULT-LLORCA, MD, PhD, graduated as a medical specialist in pathology in 1993 and in oncology in 1995. Also, in 1995, she received a PhD from the Université d’Aix-Marseille II in cellular biology and microbiology, on the topic of HER2. Frédérique PENAULT-LLORCA is currently professor of pathology at the University of Clermont-Ferrand, CEO of the Comprehensive Regional Cancer Institute Centre Jean PERRIN, Clermont-Ferrand, France, deputy director of the research team INSERM 1240 IMoST, and head of the Molecular Biology Plateform at Centre Jean Perrin. She serves as vice-president of the UNICANCER group and past chairs of the Immuno-Oncology group at UNICANCER R&D. She is a member of several pathology and oncology societies, with her main areas of expertise being female cancers. She co-chairs the French breast cancer guidelines of Nice-St Paul. Frédérique PENAULT-LLORCA has conducted various biomarkers-based research studies in breast, lung, digestive tract, prostate and thyroid cancer in relation to response to targeted therapies and immunotherapies. Frédérique PENAULT-LLORCA has participated to more than 539 peer-reviewed publications and several books on female cancers and pathologic testing methods and issues
Northwestern Medicine Cancer Center At Delnor
USA
Northwestern Medicine Cancer Center At DelnorDr. Megha Shah, DNP, FNP-BC, OCN is a Daisy Award-winning Family Nurse Practitioner and a dedicated patient advocate. With nearly 20 years of diverse healthcare experience spanning roles as a Staff Nurse, Charge Nurse, and now an Advanced Practice Registered Nurse (APRN), Megha has committed her career to clinical excellence and patient safety. She reached the pinnacle of her academic journey in 2024 by earning her terminal degree as a Doctor of Nursing Practice. An expert in her field, Megha is an Oncology Certified Nurse who actively shapes the future of healthcare. She currently leverages her leadership skills as the President of the Chicago Western Suburbs Oncology Nursing Society (CWSCONS). Her insights have reached a national audience through her work as an Associate Editor for the Clinical Journal of Oncology Nursing and through her numerous published articles. Beyond her clinical and editorial work, Megha is a passionate educator and a highly sought-after public speaker. She regularly serves as a preceptor and mentor to the next generation of nurses. Her engaging presentations cover critical healthcare topics, including oncology emergencies, the clinical power of aromatherapy, navigating end-of-life discussions, and implementing process improvements to enhance patient care. Driven by compassion and a commitment to excellence, Dr. Shah’s dedication has earned her tens of DAISY nominations, the Northwestern Excellence Award, and the Badass Nurse Award. She remains a trusted resource, leader, and inspiration for patients, colleagues, and the wider healthcare community.
Dana-Farber Cancer Institute
USA
Dana-Farber Cancer InstitutePaolo Tarantino is a breast medical oncologist and advanced fellow at Dana-Farber Cancer Institute and Harvard Medical School in Boston, MA. He obtained his medical degree from the University Federico II of Naples, Italy, and completed his medical oncology training at the European Institute of Oncology and the University of Milan, where he also earned a PhD in Clinical Research. His research focuses on the mechanisms of action of ADCs and the development of predictive biomarkers to optimize their use in oncology. He has authored more than 100 scientific publications and is actively involved in multiple clinical and translational studies aiming to improve the precision of ADC-based treatment. He serves as Associate Editor of ESMO Open, is part of the Scientific Advisory Board of multiple biotech companies in the ADC space, and serves as member of the ESMO Communication Committee.
Hirslanden Klinik St. Anna in Lucerne
Switzerland
Hirslanden Klinik St. Anna in LucernePeter Dubsky developed and heads the Tumour- and Breast Cancer Centre at the Hirslanden Klinik St. Anna in Lucerne, Switzerland. In 2023 he joined the faculty of Health Sciences and Medicine at the University of Lucerne. He is the founder of the “Network of Hirslanden Breast Cancer Centres (NHBCC)” and the “Lucerne Toolbox Consensus” which provides clinical guidance on local therapy options for breast cancer patients. In addition, he currently serves as the Vice President of the Breast Cancer group at SAKK (Swiss Group for Clinical Cancer Research). He received his MD and completed his surgical training at the Medical University of Vienna. After a post-doctoral fellowship in cancer immunology in the US and board certification in General and Visceral Surgery, he focused his clinical work and research on breast cancer. In addition to his ongoing work as a breast surgeon and clinical trialist, his active research interests focus on biomarkers in early breast cancer. He has served in several scientific committees of European oncology societies and recently joined the IBCSG scientific committee.
The University of Hong Kong
Hong Kong S.A.R
The University of Hong KongProfessor Ava Kwong is Daniel C K Yu Professor in Breast Cancer Research and Clinical Professor at The University of Hong Kong, Chief of Division of Breast Surgery at Queen Mary Hospital, Tung Wah Hospital and was Chief of Division of Breast Surgery of The University of Hong Kong-Shenzhen Hospital. Professor Kwong’s research interests focus on breast and ovarian cancer genetics, advanced surgical technologies and clinical trials in oncological treatment. She has authored chapters in textbooks and has over 300 peer-reviewed publications in reputable journals. She has received numerous grants and awards, including a commissioned grant from The Government of the Hong Kong Special Administrative Region (HKSAR) to study the risk factors of breast cancer and this cooperated study has led to the establishment of the first subsidized risk based breast screening “Breast Cancer Screening Pilot Programme” in Hong Kong. In 2019, She was received Uccio Querci della Rovere Award of BASO~ The Association for Cancer Surgery in United Kingdom. In 2023, she was awarded the HKU Faculty Clinical Service Excellence Awards. Beyond her research, Professor Kwong is active in public and community services. She is the Founder and Chairperson of the Hong Kong Hereditary Breast Cancer Family Registry, a charitable organization. She is also a member of several committees including Cancer Coordinating Committee of the Health Bureau, The Government of HKSAR and Central Committee on Cancer Service of Hospital Authority, Hong Kong.
Dr. Cipto Mangunkusumo National General Hospital
Indonesia
Dr. Cipto Mangunkusumo National General HospitalProf. Dr. dr. Soehartati Argadikoesoema Gondhowiardjo, Sp.Onk.Rad(K) is Professor of Radiation Oncology at the Faculty of Medicine, Universitas Indonesia, and a senior radiation oncologist at Dr. Cipto Mangunkusumo National General Hospital, Jakarta. With over 30 years of experience, her expertise includes thoracic, pediatric, hematological, and nasopharyngeal cancers, palliative radiotherapy, and multidisciplinary cancer care. She has contributed significantly to radiotherapy access and cancer-control programs in Indonesia and the Asia-Pacific region. She is a founder and former leader of IROS, SEAROG, and FARO, and served as a member of the IAEA Standing Advisory Group on Nuclear Applications (SAGNA). She is an honorary member of ESTRO and has received numerous national and international awards.
Asan Medical Center
Korea South
Asan Medical CenterProf. Sung-Bae Kim is a professor at Asan Medical Center, University of Ulsan, Seoul, Korea. He attained MD and Ph.D. from Kyunghee Univerisity Medical School, completed clinical training in internal medicine at Ewha Womans University, and undertook a clinical fellowship at the Division of Hematology-Oncology at Asan Medical Center. He studied at the Experimental Transplantation and Immunology, National Cancer Institute, USA in 2000 as a postdoctoral fellow. He is a member of steering committees in international clinical trials. His research interests include tumor immunotherapy, molecular imaging, early drug development, and clinical management of head and neck cancer, esophageal cancer, and breast cancer. He has authored several book chapters and written over 400 articles in oncology peer-reviewed journals. He has been the principal investigator on a number of clinical trials. He is an author or co-author of high-impact journals. He had served as Head, Breast Cancer Center, Asan Medical Center, 2018-Feb 2024 and scientific co-chair, ESMO Breast 2021-2023. He is one of high citataion researchers in 2023/ 2024 by Clarivate
Li Ka Shing Faculty of Medicine, The University of Hong Kong
Hong Kong S.A.R
Li Ka Shing Faculty of Medicine, The University of Hong KongDr. Janice Tsang is a Specialist in Medical Oncology and the Hon. Clinical Associate Professor at the Li Ka Shing Faculty of Medicine, The University of Hong Kong. Her research interests lie mainly in Breast Oncology, Geriatric Oncology, Translational Research and Psycho-Oncology. Being the first home-grown female academic medical oncologist at The University of Hong Kong, Janice was awarded the 2014 Hong Kong Ten Outstanding Young Persons Award, and the 2012 Hong Kong City Lady Award (Professional & Academic Category) among many honours bestowed upon her. She has conducted over 90 clinical trials, serving as Chair of the CTRG Audit Committee for National Cancer Institute in 2017, Chairperson for Data Monitoring Committee, Steering Committee Member for major multi-centred clinical trials, and as Advisory Board Member. As a key opinion leader in breast oncology, Janice serves as the Founding Convenor of the Hong Kong Breast Oncology Group (HKBOG) which is a member of the “Breast International Group” (BIG), and the Co-Lead for BIG ASIA emerging leadership network programme. Janice serves on the Executive Board of the Breast International Group (BIG), the Scientific Committee for the European Society of Medical Oncology (ESMO) 2025 as the Track Chair for the Metastatic Breast Cancer, and was a member of the Scientific Committee for the “Metastatic Breast Cancer Track” for the ESMO Congress 2023 in Madrid, the ESMO Breast Meetings in 2023 & 2024 in Berlin, and that for the Breast Cancer Track for past ESMO ASIA meetings including Track Chair for the Breast Cancer Scientific Committee in 2017. She also serves on the ESMO National Representatives Committee as President of the Hong Kong Cancer Therapy Society (HKCTS), the Deputy Chair for the ESMO Women for Oncology (W4O) Committee and the Founding Convenor of the Hong Kong Women for Oncology (HKW4O). Janice is also active in geriatric oncology and psycho-oncology, as a member of the International Society of Geriatric Oncology (SIOG), serving as co-track chair for translational research, and Publication Committee Member in SIOG, and the Founding Convenor of the Hong Kong Society of Geriatric Oncology (HKSGO) which is part of the SIOG, and part of the International Psycho-Oncology Society (IPOS).
Ramsay Sime Darby Healthcare
Malaysia
Ramsay Sime Darby HealthcareDr Yip is currently a consultant breast surgeon in Ramsay Sime Darby Health Care in Malaysia and is the lead clinician for the breast cancer research programme in Cancer Research Malaysia. Dr Yip was conferred Professor Emeritus by the University of Malaya in Oct 2016. She has over 250 publications in peer reviewed journals mainly on breast cancer in the Asian setting with an H index of over 40.